2.09
                                            Schlusskurs vom Vortag:
              $2.09
            Offen:
              $2.08
            24-Stunden-Volumen:
                55,884
            Relative Volume:
              0.20
            Marktkapitalisierung:
                $36.21M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              -0.48%
            1M Leistung:
              +0.48%
            6M Leistung:
                -20.83%
            1J Leistung:
              -39.60%
            Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
                  
                      Mural Oncology Plc
                    
                Sektor
                  Branche
                  Telefon
                  
                      353 1 905 8020
                    
                Adresse
                  
                      10 EARLSFORT TERRACE, DUBLIN 2
                    
                Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                MURA
                            
                             
                        Mural Oncology Plc 
                           | 
                    2.09 | 36.21M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight | 
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform | 
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight | 
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
BlackRock discloses 1.64% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.11% stake in Mural Oncology - Investing.com
BlackRock discloses 1.64% stake in Mural Oncology By Investing.com - Investing.com UK
How Mural Oncology plc stock performs during Fed tightening cyclesEarnings Performance Report & Growth Focused Stock Reports - newser.com
Combining price and volume data for Mural Oncology plcJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com
Is Mural Oncology plc a candidate for recovery play2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
What candlestick patterns are forming on Mural Oncology plc2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Exit strategy if you’re trapped in Mural Oncology plcJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Is Mural Oncology plc stock attractive for growth ETFsDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
Will Mural Oncology plc stock maintain dividend yieldMarket Risk Report & Smart Allocation Stock Tips - newser.com
Can trapped investors hope for a rebound in Mural Oncology plc2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-10-31 04:17:55 - newser.com
Why Mural Oncology plc stock is favored by pension funds2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Mural Oncology plc (MURA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Mural Oncology plc (MURA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Why AXIL stock could see breakout soonTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Chart overlay techniques for tracking Mural Oncology plcTrade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Citadel Group discloses 1.08% stake in Mural Oncology By Investing.com - Investing.com Australia
Can Mural Oncology plc stock resist sector downturnsMarket Weekly Review & Risk Controlled Swing Alerts - fcp.pa.gov.br
Citadel Group discloses 1.08% stake in Mural Oncology - Investing.com
Citadel Group discloses 0.99% stake in Mural Oncology By Investing.com - Investing.com Australia
Will Mural Oncology plc stock benefit from commodity pricesQuarterly Trade Report & Short-Term High Return Ideas - fcp.pa.gov.br
Why Mural Oncology plc stock could rally in 2025Analyst Upgrade & Accurate Entry/Exit Alerts - Fundação Cultural do Pará
Will Mural Oncology plc stock attract more institutional investorsPrice Action & Capital Efficiency Focused Ideas - fcp.pa.gov.br
Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation - MSN
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
        Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):